Hyunwoo (Tony) Kwon, MD PhD (@t_kwon92) 's Twitter Profile
Hyunwoo (Tony) Kwon, MD PhD

@t_kwon92

Heme/Onc Fellow @BIDMChealth @Harvardmed via @OSUWexMed @MUSChealth @UofT | Fan of Cancer Immunology and #MedEd. Views my own 🇰🇷 🇨🇦 🇺🇸

ID: 1515790299024527361

calendar_today17-04-2022 20:32:35

147 Tweet

146 Followers

271 Following

Ohio State Internal Medicine Residency (@ohiostateimres) 's Twitter Profile Photo

Thank you, Dr, Guibin Li, for all your years of service to our program!!! Our residents Hyunwoo (Tony) Kwon, MD PhD Prem Patel, MD and many others have gained so much from have you as a preceptor in our primary care clinic at Morehouse and on the Geriatrics team!

Thank you, Dr, Guibin Li, for all your years of service to our program!!! Our residents <a href="/t_kwon92/">Hyunwoo (Tony) Kwon, MD PhD</a> <a href="/Prem_N_Patel/">Prem Patel, MD</a> and many others have gained so much from have you as a preceptor in our primary care clinic at Morehouse and on the Geriatrics team!
BIDMC Department of Medicine (@bidmc_medicine) 's Twitter Profile Photo

Welcoming our #Match2024 BIDMC IM Residency class! We're so excited for you to join us from 46 medical schools all across the country and for the expertise you bring in areas such as global health, medical education, quality improvement, and research. Congratulations to all on Match! 🌟🎉

Welcoming our #Match2024 <a href="/BIDMC_IM/">BIDMC IM Residency</a> class! We're so excited for you to join us from 46 medical schools all across the country and for the expertise you bring in areas such as global health, medical education, quality improvement, and research. Congratulations to all on Match! 🌟🎉
Hyunwoo (Tony) Kwon, MD PhD (@t_kwon92) 's Twitter Profile Photo

Exciting to see our review led by Dr. Kai He Ohio State Medical Oncology on the role of glycoproteome in cancer biomarker discovery published online in JHO jhoonline.biomedcentral.com/articles/10.11…

Nico Gagelmann (@nicogagelmann) 's Twitter Profile Photo

Life is organization of immune systems: Rheumatology=flexible immunology BMT/cellular therapy=interventional immunology Hematology=liquid immunology Oncology=solid immunology Cardiology=vascular immunology Ophthalmology=visual immunology Pulmonology=aerial immunology

Eric K. Singhi, MD (@lungoncdoc) 's Twitter Profile Photo

#ICYMI: The treatment landscape for patients with resectable NSCLC has changed! My newly updated slide for our fellows. OncoAlert #lcsm #WCLC24

#ICYMI: The treatment landscape for patients with resectable NSCLC has changed!

My newly updated slide for our fellows. <a href="/OncoAlert/">OncoAlert</a> #lcsm #WCLC24
Hyunwoo (Tony) Kwon, MD PhD (@t_kwon92) 's Twitter Profile Photo

Consider us if you are looking to join a #HemeOnc community with flexibility in supporting individual-level needs for career development & camaraderie!!#Match2025

Giannis Mountzios (@g_mountzios) 's Twitter Profile Photo

A must-read Review on the ever-evolving field of #EGFR mut #NSCLC in@NatRevClinOncol highlighting: ➡️Strategies to improve on 1L 3rd Gen TKI mono therapy ➡️ Ways to tackle resistance post-Osi ➡️Perioperative landscape Xiuning Le MD PhD Daniel Tan Suresh S. Ramalingam, MD, FASCO IASLC #LCSM #some

A must-read  Review on the ever-evolving field of #EGFR mut #NSCLC in@NatRevClinOncol highlighting:

➡️Strategies to improve on 1L 3rd Gen TKI mono therapy
➡️ Ways to tackle resistance post-Osi
➡️Perioperative landscape

<a href="/LeXiuning/">Xiuning Le MD PhD</a> <a href="/danieltanmd/">Daniel Tan</a> <a href="/RamalingamMD/">Suresh S. Ramalingam, MD, FASCO</a> <a href="/IASLC/">IASLC</a> 
#LCSM #some
Rami Manochakian MD, FASCO Cancer Education (@rmanochakian) 's Twitter Profile Photo

🔥🚨OncoAlert Hot Off The Press Big #NewsRelease by Summit Therapeutics in time with #ASCO25 Results from the #HARMONi Phase III global trial evaluating: #Ivonescimab + #Chemo vs #Chemo in pts with advanced #EGFR+ #NSCLC after progression on 3rd gen TKI: ⭐️Statistically significant &

🔥🚨<a href="/OncoAlert/">OncoAlert</a> Hot Off The Press

Big #NewsRelease by <a href="/SMMT_TX/">Summit Therapeutics</a> in time with #ASCO25 

Results from the #HARMONi Phase III global trial evaluating:
 #Ivonescimab + #Chemo vs #Chemo in pts with advanced #EGFR+ #NSCLC after progression on 3rd gen TKI:

⭐️Statistically significant &amp;
Aakash Desai, MD, MPH, FASCO (@adesaimd) 's Twitter Profile Photo

Excited for the #LCSM session today at #ASCO25! 🚨 Here’s the latest treatment algorithm for advanced/metastatic #NSCLC 👇 How will it change after today?🔥 Can’t wait to see where new agents & trial data may fit in! LungCancerRx 🫁💊 Hem-Onc Fellows Network @Oncoalert Oncology Brothers

Excited for the #LCSM session today at #ASCO25! 

🚨 Here’s the latest treatment algorithm for advanced/metastatic #NSCLC 👇

How will it change after today?🔥 Can’t wait to see where new agents &amp; trial data may fit in! <a href="/LungCancerRx/">LungCancerRx 🫁💊</a> <a href="/HemOncFellows/">Hem-Onc Fellows Network</a> @Oncoalert <a href="/OncBrothers/">Oncology Brothers</a>
Deepa Rangachari, MD, FASCO (@deeparangachari) 's Twitter Profile Photo

The best part about ASCO is gathering with brilliant, kind humans who share a passion and tireless devotion for advancing the well-being and lives of people living with cancer— our BIDMC Hematology/Oncology Fellowship are shining stars in that universe! Mentorship + partnership = sustenance.

The best part about <a href="/ASCO/">ASCO</a> is gathering with brilliant, kind humans who share a passion and tireless devotion for advancing the well-being and lives of people living with cancer— our <a href="/BIDMC_HOFellows/">BIDMC Hematology/Oncology Fellowship</a> are shining stars in that universe! Mentorship + partnership = sustenance.